RADIOTHERAPY: seizing the opportunity in cancer care

November 22, 2018

The incidence of cancer is increasing, resulting in a rising demand for high‑quality cancer care. In 2018, there were close to 4.23 million new cases of cancer in Europe, and this number is predicted to rise by almost a quarter to 5.2 million by 2040.1 This growing demand poses a major challenge to healthcare systems and highlights the need to ensure all cancer patients have access to high-quality, efficient cancer care.

Spotlight

Bicycle Therapeutics

Bicycle Therapeutics is a biotechnology company with big ambitions. We aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (Bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology.

OTHER WHITEPAPERS
news image

Next-Generation Technology, Procedures, and Products Facilitate Biopreservation Best Practices for Cellular Therapies.

whitePaper | August 19, 2022

The quality of procedures and products used for preparing, transporting and storing cells at cryogenic temperatures have a direct impact on post-thaw viability and functionality, as well as the consistency and reliability of biological agents from a Quality perspective.

Read More
news image

THE RNA PLATFORM

whitePaper | May 26, 2022

Exploring biomarkers with the new central dogma. It can be a daunting decision for scientists to know when to focus on DNA, messenger RNA (mRNA), non-coding RNA (ncRNA) or protein biomarkers for routine clinical use, with each exhibiting its own strengths and limitations

Read More
news image

COVID-19 Vaccines Production and Analytical Chemistry Solutions

whitePaper | February 2, 2022

Vaccines work by preparing a person’s immune system to recognize and defend itself against a specific disease.

Read More
news image

Osmolality monitoring for UF/DF and CEXcapture of mAbs from mammalian cell cultures

whitePaper | July 25, 2022

The goal of each process step is to facilitate the production of a consistent product with high yield, quality, purity, and functionality. Throughout each step various Process Analytical Tools (PAT) are used to ensure quality and production metrics are maintained.

Read More
news image

Bispecific Antibodies - CMC Considerations

whitePaper | December 16, 2022

Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct binding domains.

Read More
news image

Preparing Biologics for Commercialization

whitePaper | December 14, 2022

Within the drug development process, there are several steps that occur between the laboratory and final manufacture of the drug product.

Read More

Spotlight

Bicycle Therapeutics

Bicycle Therapeutics is a biotechnology company with big ambitions. We aim to revolutionise the pharmaceutical landscape with our disruptive technology and proprietary bicyclic peptide (Bicycle®) product platform and to develop transformational new therapies for patients to improve future treatment options in oncology.

Events